Joshua Hare

Our mission is to spearhead the development of new Regenerative Therapies using a combination of stem cell biology, other basic science and the conduct of clinical trials.

The Interdisciplinary Stem Cell Institute at the University of Miami was established to capitalize on pioneering work in the use of adult stem cells for the repair of malfunctioning human organs. The goal of the Institute is to find new treatments for heart disease, neurological disease, bone disease, diabetes, cancer, eye diseases and other chronic, debilitating, or incurable diseases. University of Miami scientists have led in the development of procedures to extract adult stem cells from bone marrow, and have conducted ground breaking research in cell-based therapy for the diseased human heart. This type of procedure can be adapted for other diseased tissues, such as liver, lung, spinal cord disease, bone disease, and diabetes. The end result of stem cell therapy is a cure for diseases that have as yet defied conventional therapies.

Our methods are ethical, rigorous, and straightforward. We are committed to meticulous, innovative and interdisciplinary research. We work in collaboration with partners in the pharmaceutical, biotechnology, and medical device industries to ensure that our results translate smoothly and safely from the laboratory to the clinic.

Our vision is to create a uniquely integrated research community working together to

    *understand the biology of adult stem cells,
    *rapidly apply this knowledge to regenerative medicine, and
    *advance therapeutic opportunities for various hard-to-treat diseases.